MA46291A - Agents anti-cancéreux et leur préparation - Google Patents
Agents anti-cancéreux et leur préparationInfo
- Publication number
- MA46291A MA46291A MA046291A MA46291A MA46291A MA 46291 A MA46291 A MA 46291A MA 046291 A MA046291 A MA 046291A MA 46291 A MA46291 A MA 46291A MA 46291 A MA46291 A MA 46291A
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- cancer agents
- cancer
- agents
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662398783P | 2016-09-23 | 2016-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46291A true MA46291A (fr) | 2019-07-31 |
Family
ID=61690726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046291A MA46291A (fr) | 2016-09-23 | 2017-09-22 | Agents anti-cancéreux et leur préparation |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10858371B2 (fr) |
| EP (1) | EP3515492B1 (fr) |
| JP (1) | JP7111722B2 (fr) |
| KR (1) | KR102646702B1 (fr) |
| CN (1) | CN109862916A (fr) |
| AU (1) | AU2017331260B2 (fr) |
| BR (1) | BR112019005885A2 (fr) |
| CA (1) | CA3037883A1 (fr) |
| DK (1) | DK3515492T3 (fr) |
| IL (1) | IL265521B2 (fr) |
| MA (1) | MA46291A (fr) |
| MX (1) | MX394670B (fr) |
| RU (1) | RU2019111768A (fr) |
| WO (1) | WO2018057897A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017331260B2 (en) | 2016-09-23 | 2024-11-07 | Purdue Research Foundation | Anti-cancer agents and preparation thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR901464A (fr) | 1943-01-23 | 1945-07-27 | Boehringer & Soehne Gmbh | Procédé d'obtention de vanilline |
| US7825267B2 (en) * | 2006-09-08 | 2010-11-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Synthesis of FR901464 and analogs with antitumor activity |
| WO2009031999A1 (fr) * | 2007-09-07 | 2009-03-12 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Fr901464 et analogues présentant une activité antitumorale, et procédé de préparation de ces composés |
| CN101417934B (zh) * | 2007-10-24 | 2012-04-18 | 国鼎生物科技股份有限公司 | 分离自牛樟芝萃取物的化合物 |
| NZ587706A (en) | 2008-03-18 | 2012-12-21 | Genentech Inc | Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
| WO2009155606A1 (fr) * | 2008-06-21 | 2009-12-23 | St. Jude Children's Research Hospital | Composés anticancéreux et procédés de fabrication et d'utilisation correspondants |
| US20150025017A1 (en) * | 2012-02-28 | 2015-01-22 | Fred Hutchinson Cancer Research Center | Compositions and methods for treating cancer |
| MX340090B (es) * | 2012-11-05 | 2016-06-23 | Pfizer | Analogos de spliceostatina. |
| WO2014100367A1 (fr) * | 2012-12-21 | 2014-06-26 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Synthèse de fr901464 et de ses analogues à activité antitumorale |
| US20140274979A1 (en) * | 2013-03-13 | 2014-09-18 | Golden Biotechnology Corporation | Method for the treatment of fatty liver disease |
| CN105611930B (zh) | 2013-07-15 | 2021-03-02 | 亥姆霍兹慕尼黑中心-德国环境与健康研究中心（股份有限公司） | 作为非凋亡调控性细胞死亡抑制剂的螺环喹喔啉衍生物 |
| KR102092569B1 (ko) * | 2013-09-17 | 2020-03-25 | 엘지디스플레이 주식회사 | 터치 스크린 일체형 디스플레이 장치와 이의 구동 방법 |
| US10000505B2 (en) | 2013-11-19 | 2018-06-19 | Purdue Research Foundation | Anti-cancer agents and preparation thereof |
| EP3468976A4 (fr) * | 2016-06-08 | 2019-11-27 | William Marsh Rice University | Dérivés de la thailanstatine a, méthodes de traitement et méthodes de synthèse de ceux-ci |
| AU2017331260B2 (en) | 2016-09-23 | 2024-11-07 | Purdue Research Foundation | Anti-cancer agents and preparation thereof |
-
2017
- 2017-09-22 AU AU2017331260A patent/AU2017331260B2/en active Active
- 2017-09-22 KR KR1020197011144A patent/KR102646702B1/ko active Active
- 2017-09-22 MX MX2019003368A patent/MX394670B/es unknown
- 2017-09-22 RU RU2019111768A patent/RU2019111768A/ru unknown
- 2017-09-22 DK DK17853991.2T patent/DK3515492T3/da active
- 2017-09-22 IL IL265521A patent/IL265521B2/en unknown
- 2017-09-22 CN CN201780065546.7A patent/CN109862916A/zh active Pending
- 2017-09-22 CA CA3037883A patent/CA3037883A1/fr active Pending
- 2017-09-22 BR BR112019005885-0A patent/BR112019005885A2/pt unknown
- 2017-09-22 US US16/335,378 patent/US10858371B2/en active Active
- 2017-09-22 MA MA046291A patent/MA46291A/fr unknown
- 2017-09-22 JP JP2019537750A patent/JP7111722B2/ja active Active
- 2017-09-22 WO PCT/US2017/052967 patent/WO2018057897A1/fr not_active Ceased
- 2017-09-22 EP EP17853991.2A patent/EP3515492B1/fr active Active
-
2020
- 2020-11-09 US US17/092,829 patent/US11851441B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR102646702B1 (ko) | 2024-03-11 |
| RU2019111768A (ru) | 2020-10-23 |
| IL265521A (en) | 2019-05-30 |
| IL265521B1 (en) | 2024-05-01 |
| WO2018057897A1 (fr) | 2018-03-29 |
| IL265521B2 (en) | 2024-09-01 |
| US20190218228A1 (en) | 2019-07-18 |
| US20210395265A1 (en) | 2021-12-23 |
| AU2017331260A1 (en) | 2019-05-16 |
| EP3515492A1 (fr) | 2019-07-31 |
| CN109862916A (zh) | 2019-06-07 |
| JP2019529563A (ja) | 2019-10-17 |
| MX2019003368A (es) | 2019-09-16 |
| AU2017331260B2 (en) | 2024-11-07 |
| BR112019005885A2 (pt) | 2020-06-02 |
| CA3037883A1 (fr) | 2018-03-29 |
| RU2019111768A3 (fr) | 2020-11-24 |
| EP3515492B1 (fr) | 2023-07-26 |
| KR20190077340A (ko) | 2019-07-03 |
| US11851441B2 (en) | 2023-12-26 |
| MX394670B (es) | 2025-03-11 |
| US10858371B2 (en) | 2020-12-08 |
| EP3515492A4 (fr) | 2020-04-08 |
| DK3515492T3 (da) | 2023-08-28 |
| JP7111722B2 (ja) | 2022-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2021006I1 (el) | Αντιγριπικο πολυκυκλικο παραγωγο πυριδονης και προφαρμακο αυτου | |
| EP3384077A4 (fr) | Surfaces fonctionnalisées et leur préparation | |
| CL2018000813A1 (es) | Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso. | |
| IL258931A (en) | Therapeutic compounds and methods | |
| IL262751A (en) | Pharmaceutical compositions with enhanced permeation | |
| MA46525A (fr) | Anticorps anti-lag-3 et compositions | |
| MA44659A (fr) | Anticorps anti-tim-3 et compositions | |
| PL3423087T3 (pl) | Skojarzona terapia przeciwnowotworowa | |
| EP3513809A4 (fr) | Composition médicinale | |
| DK3411393T3 (da) | Administration af manipulerede t-celler til behandling af cancere i centralnervesystemet | |
| MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
| EP3636246A4 (fr) | Préparation cosmétique émulsionnée eau-dans-huile | |
| EP3437678A4 (fr) | Seringue pré-emballée | |
| EP3310376A4 (fr) | Agents thérapeutiques modifiés et compositions associées | |
| DK3380139T3 (da) | Medikamentadministrationsanordning | |
| IL256381A (en) | Cryoprecipitate compositions and methods of preparation thereof | |
| EP3316685A4 (fr) | Compositions pharmaceutiques lyophilisées | |
| MA44987A (fr) | Formulations de médicaments améliorées | |
| DK3275452T3 (da) | Farmaceutisk sammensætning med silibinin | |
| EP3359962A4 (fr) | Préparation et profilage sanguins | |
| BR112016011430A2 (pt) | agentes anticâncer e preparação dos mesmos. | |
| EP3454872C0 (fr) | Tissu adipeux et ses utilisations médicales | |
| EP3353159A4 (fr) | Cytotoxines modifiées et leur utilisation thérapeutiques | |
| DK3349825T3 (da) | Lægemiddeladministrationsanordning | |
| MA40524A (fr) | Dérivés d'adrénomédulline stabilisés et leur utilisation |